Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: Coreceptor usage and neutralization phenotypes

Journal of General Virology

Volumn 91, Issue 9, 2010, Pages 2374-2380

  Koh, Willie W L ^a   Forsman, Anna ^a   Hué, Stéphane ^a   Van Der Velden, Gisela J ^a,d   Yirrell, David L ^b   McKnight, Áine ^c   Weiss, Robin A ^a   Aasa Chapman, Marlén M I ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CLONE; ENVELOPE GENE; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; UNITED KINGDOM; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

AFRICA; CLONING, MOLECULAR; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENES, ENV; GLYCOSYLATION; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; NEUTRALIZATION TESTS; PHYLOGENY; RECEPTORS, CCR3; RECEPTORS, HIV; SCOTLAND;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1; REPLICATION COMPETENT VIRUSES;

EID: 77956290682     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.022228-0     Document Type: Article

References (42)

1. Aasa-Chapman, M. M., Aubin, K., Williams, I. & McKnight, A. (2006a). Primary CCR5 only using HIV-1 isolates does not accurately represent the in vivo replicating quasi-species. Virology 351, 489-496.
2. Aasa-Chapman, M. M., Seymour, C. R., Williams, I. & McKnight, A. (2006b). Novel envelope determinants for CCR3 use by human immunodeficiency virus. J Virol 80, 10884-10889.
3. Abebe, A., Demissie, D., Goudsmit, J., Brouwer, M., Kuiken, C. L., Pollakis, G., Schuitemaker, H., Fontanet, A. L. & Rinke de Wit, T. F. (1999). HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 13, 1305-1311.
4. Agrawal, L., Maxwell, C. R., Peters, P. J., Clapham, P. R., Liu, S. M., Mackay, C. R. & Strayer, D. S. (2009). Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain microglia. J Gen Virol 90, 710-722.
5. Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S. & other authors (2004). Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 78, 13232-13252.
6. Bjorndal, A., Sonnerborg, A., Tscherning, C., Albert, J. & Fenyo, E. M. (1999). Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 15, 647-653.
7. Brown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J., Sanders-Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E. & Polonis, V. R. (2005). Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01-AE, and CRF02-AG, for the development and assessment of candidate vaccines. J Virol 79, 6089-6101.
8. Bures, R., Morris, L., Williamson, C., Ramjee, G., Deers, M., Fiscus, S. A., Abdool-Karim, S. & Montefiori, D. C. (2002). Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol 76, 2233-2244.
9. Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L. & other authors (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071.
10. Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R. & Wilson, I. A. (2005). Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22, 163-173.
11. Cardozo, T., Kimura, T., Philpott, S., Weiser, B., Burger, H. & Zolla-Pazner, S. (2007). Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 23, 415-426.
12. Cecilia, D., Kulkarni, S. S., Tripathy, S. P., Gangakhedkar, R. R., Paranjape, R. S. & Gadkari, D. A. (2000). Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 271, 253-258.
13. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. & other authors (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
14. Cilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A. & Morris, L. (2003). The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 77, 4449-4456.
15. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E. & other authors (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
16. Fernandez-Garcia, A., Cuevas, M. T., Munoz-Nieto, M., Ocampo, A., Pinilla, M., Garcia, V., Serrano-Bengoechea, E., Lezaun, M. J., Delgado, E. & other authors (2009). Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections. AIDS Res Hum Retroviruses 25, 93-102.
17. Forsman, A., Beirnaert, E., Aasa-Chapman, M. M., Hoorelbeke, B., Hijazi, K., Koh, W., Tack, V., Szynol, A., Kelly, C. & other authors (2008). Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J Virol 82, 12069-12081.
18. Gray, E. S., Meyers, T., Gray, G., Montefiori, D. C. & Morris, L. (2006). Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B. PLoS Med 3, e255.
19. Hoffman, T. L., Stephens, E. B., Narayan, O. & Doms, R. W. (1998). HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc Natl Acad Sci U S A 95, 11360-11365.
20. Isaacman-Beck, J., Hermann, E. A., Yi, Y., Ratcliffe, S. J., Mulenga, J., Allen, S., Hunter, E., Derdeyn, C. A. & Collman, R. G. (2009). Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol 83, 8208-8220.
21. Koh, W. W., Steffensen, S., Gonzalez, M., Hoorelbeke, B., Gorlani, A., Szynol, A., Forsman, A., Aasa-Chapman, M. M., de Haard, H. & other authors (2010). Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1. J Biol Chem 285, 19116-19124.
22. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P. & other authors (2005). Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79, 10108-10125.
23. Li, B., Decker, J. M., Johnson, R. W., Bibollet-Ruche, F., Wei, X., Mulenga, J., Allen, S., Hunter, E., Hahn, B. H. & other authors (2006a). Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 80, 5211-5218.
24. Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G. & other authors (2006b). Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 80, 11776-11790.
25. McKeating, J. A., Zhang, Y. J., Arnold, C., Frederiksson, R., Fenyo, E. M. & Balfe, P. (1996). Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera. Virology 220, 450-460.
26. Montefiori, D. C. (2004). Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays. In Current Protocols in Immunology, pp. 12.11.1-12.11.15. Edited by A. M. K. J. E. Coligan, D. H. Margulies, E. M. Shevach, W. Strober & R. Coico. New York, NY: John Wiley & Sons.
27. Morris, L., Cilliers, T., Bredell, H., Phoswa, M. & Martin, D. J. (2001). CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 17, 697-701.
28. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67, 6642-6647.
29. Nedellec, R., Coetzer, M., Shimizu, N., Hoshino, H., Polonis, V. R., Morris, L., Martensson, U. E., Binley, J., Overbaugh, J. & Mosier, D. E. (2009). Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol 83, 8353-8363.
30. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R. & Kwong, P. D. (2004). Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78, 10724-10737.
31. Rao, V. R., Sas, A. R., Eugenin, E. A., Siddappa, N. B., Bimonte-Nelson, H., Berman, J. W., Ranga, U., Tyor, W. R. & Prasad, V. R. (2008). HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 28, 10010-10016.
32. Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D. & Moore, J. P. (2002). Themannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76, 7293-7305.
33. Scanlan, C. N., Pantophlet, R., Wormald, M. R., Ollmann Saphire, E., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M. & Burton, D. R. (2002). The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J Virol 76, 7306-7321.
34. Soda, Y., Shimizu, N., Jinno, A., Liu, H. Y., Kanbe, K., Kitamura, T. & Hoshino, H. (1999). Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem Biophys Res Commun 258, 313-321.
35. UNAIDS/WHO (2009). AIDS epidemic update: November 2009.
36. Wu, L., Yang, Z. Y., Xu, L., Welcher, B., Winfrey, S., Shao, Y., Mascola, J. R. & Nabel, G. J. (2006). Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope. Vaccine 24, 4995-5002.
37. Xiao, L., Owen, S. M., Goldman, I., Lal, A. A., deJong, J. J., Goudsmit, J. & Lal, R. B. (1998). CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240, 83-92.
38. Yirrell, D. L., Shaw, L., Burns, S. M., Cameron, S. O., Quigg, M., Campbell, E. & Goldberg, D. (2004). HIV-1 subtype in Scotland: the establishment of a national surveillance system. Epidemiol Infect 132, 693-698.
39. Zhang, H., Hoffmann, F., He, J., He, X., Kankasa, C., West, J. T., Mitchell, C. D., Ruprecht, R. M., Orti, G. & Wood, C. (2006). Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology 3, 73.
40. Zheng, N. N. & Daniels, R. S. (2001). Maintenance of glycoprotein-determined phenotype in an HIV type 1 (pNL43) env gene-cassetting system. AIDS Res Hum Retroviruses 17, 1501-1506.
41. Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S. H., Yang, X., Zhang, M. Y., Zwick, M. B. & other authors (2007). Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445, 732-737.
42. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H. & other authors (2001). Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 75, 10892-10905.